Xynomic Pharmaceuticals IPO

Xynomic Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing oncology drug candidates.

Register for Details

For more details on financing and valuation for Xynomic Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Xynomic Pharmaceuticals's ticker symbol?

XYNO

Learn more about Xynomic Pharmaceuticals

Forge green plus iconForge green minus icon

What is Xynomic Pharmaceuticals funding to date?

Xynomic Pharmaceuticals has raised $21.8MM.
Forge green plus iconForge green minus icon

When was Xynomic Pharmaceuticals founded?

Xynomic Pharmaceuticals was founded in 2016.